State Street’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.9M | Buy |
4,708,419
+512,089
| +12% | +$4.88M | ﹤0.01% | 1862 |
|
|
2025
Q4 | $50.9M | Buy |
4,196,330
+736,318
| +21% | +$8.94M | ﹤0.01% | 1735 |
|
|
2025
Q3 | $40.4M | Sell |
3,460,012
-49,098
| -1% | -$587K | ﹤0.01% | 1831 |
|
|
2025
Q2 | $32.6M | Buy |
3,509,110
+117,260
| +3% | +$918K | ﹤0.01% | 1918 |
|
|
2025
Q1 | $24.9M | Sell |
3,391,850
-98,039
| -3% | -$753K | ﹤0.01% | 2003 |
|
|
2024
Q4 | $29.8M | Buy |
3,489,889
+13,597
| +0.4% | +$133K | ﹤0.01% | 1989 |
|
|
2024
Q3 | $30.2M | Sell |
3,476,292
-444,371
| -11% | -$3.66M | ﹤0.01% | 1974 |
|
|
2024
Q2 | $26.8M | Buy |
3,920,663
+1,518,283
| +63% | +$9.37M | ﹤0.01% | 2013 |
|
|
2024
Q1 | $21.9M | Buy |
2,402,380
+862,805
| +56% | +$6.12M | ﹤0.01% | 2155 |
|
|
2023
Q4 | $6.87M | Sell |
1,539,575
-242,290
| -14% | -$716K | ﹤0.01% | 2783 |
|
|
2023
Q3 | $5.6M | Buy |
1,781,865
+205,652
| +13% | +$842K | ﹤0.01% | 2868 |
|
|
2023
Q2 | $8.13M | Buy |
1,576,213
+83,254
| +6% | +$495K | ﹤0.01% | 2753 |
|
|
2023
Q1 | $7.87M | Buy |
1,492,959
+105,627
| +8% | +$502K | ﹤0.01% | 2792 |
|
|
2022
Q4 | $3.9M | Sell |
1,387,332
-12,014
| -0.9% | -$39.8K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $5.81M | Sell |
1,399,346
-12,481
| -0.9% | -$62.9K | ﹤0.01% | 2992 |
|
|
2022
Q2 | $5.68M | Sell |
1,411,827
-293,107
| -17% | -$1.11M | ﹤0.01% | 3043 |
|
|
2022
Q1 | $8.44M | Sell |
1,704,934
-25,422
| -1% | -$141K | ﹤0.01% | 2904 |
|
|
2021
Q4 | $12.1M | Buy |
1,730,356
+57,306
| +3% | +$445K | ﹤0.01% | 2802 |
|
|
2021
Q3 | $16.7M | Sell |
1,673,050
-65,422
| -4% | -$735K | ﹤0.01% | 2591 |
|
|
2021
Q2 | $24.7M | Buy |
1,738,472
+220,855
| +15% | +$3.36M | ﹤0.01% | 2383 |
|
|
2021
Q1 | $24.9M | Buy |
1,517,617
+62,663
| +4% | +$1.21M | ﹤0.01% | 2232 |
|
|
2020
Q4 | $30.1M | Buy |
1,454,954
+305,487
| +27% | +$4.54M | ﹤0.01% | 1978 |
|
|
2020
Q3 | $8.75M | Buy |
1,149,467
+243,485
| +27% | +$2.02M | ﹤0.01% | 2502 |
|
|
2020
Q2 | $7.55M | Buy |
905,982
+89,781
| +11% | +$595K | ﹤0.01% | 2567 |
|
|
2020
Q1 | $4.04M | Buy |
816,201
+109,634
| +16% | +$541K | ﹤0.01% | 2735 |
|
|
2019
Q4 | $2.79M | Buy |
706,567
+33,671
| +5% | +$117K | ﹤0.01% | 3126 |
|
|
2019
Q3 | $2.05M | Buy |
672,896
+92,165
| +16% | +$412K | ﹤0.01% | 3211 |
|
|
2019
Q2 | $2.56M | Buy |
580,731
+59,405
| +11% | +$220K | ﹤0.01% | 3145 |
|
|
2019
Q1 | $2.07M | Buy |
521,326
+36,649
| +8% | +$147K | ﹤0.01% | 3134 |
|
|
2018
Q4 | $1.93M | Buy |
484,677
+11,383
| +2% | +$62.7K | ﹤0.01% | 3133 |
|
|
2018
Q3 | $3.26M | Buy |
473,294
+40,314
| +9% | +$253K | ﹤0.01% | 3059 |
|
|
2018
Q2 | $2.92M | Buy |
432,980
+59,057
| +16% | +$406K | ﹤0.01% | 3103 |
|
|
2018
Q1 | $2.44M | Buy |
373,923
+21,782
| +6% | +$123K | ﹤0.01% | 3086 |
|
|
2017
Q4 | $1.56M | Buy |
352,141
+261
| +0.1% | +$1.33K | ﹤0.01% | 3255 |
|
|
2017
Q3 | $2.18M | Sell |
351,880
-20,043
| -5% | -$129K | ﹤0.01% | 3176 |
|
|
2017
Q2 | $3.45M | Buy |
371,923
+40,782
| +12% | +$395K | ﹤0.01% | 2917 |
|
|
2017
Q1 | $3.08M | Buy |
331,141
+92,220
| +39% | +$768K | ﹤0.01% | 2929 |
|
|
2016
Q4 | $2M | Buy |
238,921
+42,761
| +22% | +$332K | ﹤0.01% | 3102 |
|
|
2016
Q3 | $1.35M | Sell |
196,160
-9,149
| -4% | -$55.8K | ﹤0.01% | 3116 |
|
|
2016
Q2 | $1.01M | Sell |
205,309
-277
| -0.1% | -$2.74K | ﹤0.01% | 3271 |
|
|
2016
Q1 | $1.99M | Buy |
205,586
+24,939
| +14% | +$189K | ﹤0.01% | 3007 |
|
|
2015
Q4 | $1.69M | Buy |
180,647
+3,698
| +2% | +$39.9K | ﹤0.01% | 3052 |
|
|
2015
Q3 | $2.48M | Buy |
176,949
+52,049
| +42% | +$1.05M | ﹤0.01% | 2905 |
|
|
2015
Q2 | $2.63M | Buy |
124,900
+54,771
| +78% | +$1.36M | ﹤0.01% | 2959 |
|
|
2015
Q1 | $2.94M | Buy |
70,129
+23,029
| +49% | +$757K | ﹤0.01% | 2857 |
|
|
2014
Q4 | $1.11M | Buy |
47,100
+7,200
| +18% | +$121K | ﹤0.01% | 3238 |
|
|
2014
Q3 | $596K | Buy |
+39,900
| New | +$590K | ﹤0.01% | 3355 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
